The Global Market for Wound Debridement Products is Projected to Reach US$1.3 Billion by 2022

Growing Emphasis on Wound Bed Preparation for Effective Wound Management to Drive the Global Wound Debridement Products Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Wound Debridement Products market. The global market for Wound Debridement Products is projected to reach US$1.3 billion by 2022, driven by the growing emphasis on wound bed preparation to optimize healing conditions coupled with the development of innovative wound care solutions for debridement in chronic and acute wounds.

Wound debridement constitutes an important element of wound bed preparation, wherein contaminated, dead or adherent tissue is removed from the wound to accelerate the healing process. Debridement promotes and expedites healing of wound by arresting further damage to the tissue, removing eschar tissue and contaminants to reduce bacterial load, and prepare the wound bed for advanced procedures such as grafting. The growth in the wound debridement products market is driven by factors such as growing incidence of chronic wounds, and increasing acceptance of wound bed preparation  as an integral part of wound management. In addition, the market stands to benefit from the growing emphasis on  faster healing of wounds, given the surging healthcare costs and corresponding need to reduce patient stays at hospitals. Another factor sustaining market growth is the need for repeated debridement or maintenance debridement for chronic wounds.

With debridement constituting a critical element of wound bed preparation, research is underway to develop methods that are highly efficient, less painful and less time consuming and cost effective. Some of novel technologies and products introduced in recent years include ultrasound, hydrosurgery, monofilament polyester fibre pad, and plasma-mediated bipolar radio frequency ablation. The ultrasound technology is emerging as an effective tool for easy debridement of non-viable soft tissue and infected bones. Enzymatic debridement is another method gaining interest to manage diabetic foot ulcers. Over the years, burn eschar debridement has also progressed from traditional time-consuming methods involving the use of dressings with antimicrobial agents to interventions employing hydrotherapy and chemical debridement for selective degradation of nonviable tissue.

As stated by the new market research report on Wound Debridement Products, the United States represents the largest market worldwide. Asia Pacific is forecast to emerge as the fastest growing market with a CAGR of  8.1 % over the analysis period led by factors such as growing population and a commensurate increase in healthcare needs, epidemic rise in obesity and diabetes and a parallel increase in population susceptible to wound development, aging population given that aged skin is more susceptible to developing chronic wounds than younger skin, improving healthcare infrastructure and access to affordable healthcare and the rising prominence of medical tourism in the field of rehabilitation, pain management and wound care.

Major players in the market include Advanced Medical Solutions Group plc, Coloplast, Derma Sciences Inc., Misonix, PuriCore plc, Lohmann & Rauscher GmbH, MediWound Ltd., Smith & Nephew Plc, and Soering GmbH, among others.

The research report titled “Wound Debridement Products: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, mergers, acquisitions and other strategic industry activities of major companies worldwide. The report provides market estimates and projections in US dollars for all major geographic markets including the United States, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.